These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fighting bacterial resistance at the root: need for adapted EMEA guidelines. Andremont A; Bonten M; Kluytmans J; Carmeli Y; Cars O; Harbarth S Lancet Infect Dis; 2011 Jan; 11(1):6-8. PubMed ID: 21183140 [No Abstract] [Full Text] [Related]
8. Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil. Toledo PV; Arend LN; Pilonetto M; Costa Oliveira JC; Luhm KR; J Hosp Infect; 2012 Apr; 80(4):351-3. PubMed ID: 22382275 [TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868 [TBL] [Abstract][Full Text] [Related]
10. Community-acquired respiratory infections: spectrum of organisms and treatment. McKellar PP J Med Liban; 2000; 48(4):264-9. PubMed ID: 11214199 [TBL] [Abstract][Full Text] [Related]
11. Increasing prevalence of antimicrobial resistance among organisms isolated from blood culture in a Singapore hospital. Kumarasinghe G; Chow C; Yin LH; Hong SY; Bassett DC Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):116-22. PubMed ID: 7825001 [TBL] [Abstract][Full Text] [Related]
12. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. Ubukata K J Infect Chemother; 2003 Dec; 9(4):285-91. PubMed ID: 14691647 [No Abstract] [Full Text] [Related]
13. [Problems in and future prospects for today's antibiotics]. Kono S Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2165-7. PubMed ID: 17168386 [No Abstract] [Full Text] [Related]
14. Community-associated MRSA from the Indian subcontinent. Tong SY; Kearns AM Lancet Infect Dis; 2013 Sep; 13(9):734-5. PubMed ID: 23969208 [No Abstract] [Full Text] [Related]
15. The menace of beta-lactamase production on antibiotic prescription in community acquired-infections in Nigeria. Oyelese AO; Oyewo EA Afr J Med Med Sci; 1995 Jun; 24(2):125-30. PubMed ID: 8669389 [TBL] [Abstract][Full Text] [Related]
16. Patients hospitalized with pneumonia: determining the need for broad-spectrum antibiotic therapy. Kollef MH; Micek ST Clin Infect Dis; 2012 Feb; 54(4):479-82. PubMed ID: 22109952 [No Abstract] [Full Text] [Related]
17. Extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli: changing the therapy for hospital-acquired and community-acquired infections. Helfand MS; Bonomo RA Clin Infect Dis; 2006 Dec; 43(11):1415-6. PubMed ID: 17083013 [No Abstract] [Full Text] [Related]
18. Community-associated methicillin-resistant Staphylococcus aureus disease in children in Taiwan: the importance of antibiotic stewardship. Lo WT; Wang CC J Formos Med Assoc; 2009 Oct; 108(10):751-3. PubMed ID: 19864194 [No Abstract] [Full Text] [Related]
19. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]